ArticleClinical & translational immunology2023

Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.

Rebecca C Abbott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.